The Evolution of Systemic Therapy for Advanced Urothelial Cancer

  • Registration Closed

Hear an in-depth discussion on the use of biomarkers to guide treatment decisions in localized bladder cancer, first line and systemic therapy for the treatment of metastatic urothelial cancer; and learn about the nuances of using immunotherapy to treat this cancer type.

Presented by: Elizabeth Plimack, MD, MS Chief, Division of Genitourinary Medical Oncology Professor, Department of Hematology/Oncology, Fox Chase Cancer Center, Temple University

This webinar is part of a six-part clinical education series hosted by the Hawaii Society of Clinical Oncology—a Chapter Member of the Association of Community Cancer Centers. 

Key:

Complete
Failed
Available
Locked
The Evolution of Systemic Therapy for Advanced Urothelial Cancer
Select the "View On-Demand Recording" button to begin.  |  120 minutes
Select the "View On-Demand Recording" button to begin.  |  120 minutes

ADDITIONAL HANDOUTS TO SUPPLEMENT YOUR LEARNING

The Hawaii Society of Clinical Oncology (HSCO) is a Chapter Member of the Association of Community Cancer Centers (ACCC). HSCO members receive access to valuable educational content and targeted resources through ACCC to support their professional development.

·  Optimizing Outcomes for Urothelial Carcinoma provides guidance on practical issues and barriers associated with new and emerging therapies.

· The ACCC COVID-19 Resource Center contains webcasts, podcasts, and blogs, and resources on the pandemic from federal and professional organizations.

· The ACCC COVID-19 Financial Advocacy Resources Hub features new and updated foundation assistance, updates to manufacturer assistance programs, and Medicare and Medicaid coverage updates.

· HSCO members can connect in real-time through members-only virtual discussion forum on ACCCeXchange. Within this forum, HSCO members from every profession involved in cancer care delivery ask and answer questions, discuss common challenges, and share knowledge and experience.  Join the discussion and connect with your peers.

·  Tap into the value of HSCO membership! Visit our membership page for more information on how you can join our community of professionals. If you’re unsure of your membership status, please contact our membership department today.

· The ACCCeLearning portal makes it easy to find education relevant to your needs and interests. Accessible on any device and at any time, courses are available in a variety of formats, so you can listen, watch, read or interact in ways that best suit your needs. Health professionals can claim CME/CPE/CNE credit for all applicable activities. Since you’re already logged in, take a look around today!

Elizabeth Plimack, MD, MS

Chief, Division of Genitourinary Medical Oncology , Fox Chase Cancer Center Professor, Department of Hematology/Oncology, Temple University

Ian Okazaki, MD

Medical Oncologist, Straub Clinic & Hospital, Inc.

Ian Okazaki, MD, is a medical oncologist affiliated with multiple hospitals in the Honolulu area, including Maui Memorial Medical Center and Pali Momi Medical Center. He received his medical degree from the University of Hawaii John A. Burns School of Medicine and has been in practice for more than 20 years.

Michael Carney, MD (Moderator)

Obstetrician/Gynecologist

University of Hawaii Cancer Center

Michael Carney, MD, is an obstetrician/gynecologist in Honolulu, Hawaii. He is affiliated with Kapiolani Medical Center for Women & Children, The Queen’s Medical Center, and Maui Memorial Medical Center. Dr. Carney has extensive experience treating women for ovarian, cervical, and gynecological cancers. Prior to joining the Women’s Cancer Center and the John A. Burns School of Medicine, he worked at the prestigious Huntsman Cancer Institute. Dr. Carney completed both his obstetrics and gynecology residency and fellowship in gynecologic oncology at the Duke University Medical Center. He has developed clinical trials and is currently studying the molecular genetics of gynecological cancer to better understand and treat the disease.